Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: GLP-1RA, Topics Jun 20 | 2018Novo’s Oral Semaglutide Beats Victoza and JanuviaPurchase Blast
$599
Posted in: Other, Topics Jun 19 | 2018Novo Partners with Kallyope for Early-Stage Diabetes/Obesity R&DPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other, Topics Jun 19 | 2018Thoughts on Glooko+DreaMed Data Services Franchise to Compete with Medtronic’s CareLinkPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Jun 19 | 2018Thoughts on Medtronic iPro2 Updated Professional CGM AppPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Jun 18 | 2018GlySens Implantable CGM Trial CompletedPurchase Blast
$599
Posted in: Insulin Delivery, Topics Jun 18 | 2018Montreal dual-hormone AP System: Implications to Closed-Loop DevelopmentPurchase Blast$599
Posted in: Bolus Insulin, Insulin Delivery, Topics Jun 15 | 2018New Fiasp/Medtronic 670G Study on CT.govPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Jun 13 | 2018LifeScan Sold for $2.1B; New Business Model PossiblePurchase Blast
$599
Posted in: Glucose Monitoring, Topics Jun 11 | 2018Dexcom Medicare Smartphone Integration; G6 Receives CE MarkPurchase Blast
$599
Posted in: Glucagon, Topics Jun 08 | 2018Zealand Announces Additional Topline Dasiglucagon ResultsPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Topics Jun 07 | 2018CGM Swapping Supported by Senseonics/Beta Bionics PartnershipPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Topics Jun 05 | 2018FENIX Analysis: Post-AACE 2018 Device Promotional MaterialPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, SGLT2i, Topics Jun 04 | 2018FENIX Analysis: Post-AACE 2018 Drug Promotional MaterialPurchase Blast
$599
Posted in: Insulin Delivery, Topics Jun 04 | 2018Insulet Omnipod DASH Cleared by FDAPurchase Blast
$599
Posted in: SGLT2i, Topics Jun 01 | 2018FENIX Analysis: SGLT2i HF CVOTs and Stopping Early ScenariosPurchase Blast$599
Posted in: GLP-1RA, SGLT2i, Topics May 29 | 2018Novo’s oral semaglutide beats Jardiance in PIONEER 2Purchase Blast$599
Posted in: Glucagon, Topics May 29 | 2018Zealand completes 2nd Ph3 pivotal rescue trial for dasiglucagonPurchase Blast